Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MLA | Ann: Removal from Official List (COB 30/11/2017) | 30/11/17 | 0 | 727 | |||
|
|||||||
MLA | Ann: IMPLEMENTATION OF SCHEME OF ARRANGEMENT | 30/11/17 | 0 | 866 | |||
|
|||||||
MLA | Ann: LODGMENT OF COURT ORDERS WITH ASIC | 12:16 | 0 | 463 | |||
|
|||||||
MLA | Ann: Suspension from Official Quotation (COB 20/11/2017) | 09:57 | 0 | 531 | |||
|
|||||||
MLA | Ann: Appendix 4C - quarterly | 18/11/17 | 10 | 3.0K | |||
|
|||||||
MLA | Ann: MLA SHAREHOLDERS APPROVE SCHEME | 17/11/17 | 0 | 439 | |||
|
|||||||
MLA | Ann: COURT APPROVES SCHEME OF ARRANGEMENT | 17/11/17 | 0 | 611 | |||
|
|||||||
MLA | Ann: Substituted annexure to announcement re Scheme Meeting | 15/11/17 | 0 | 535 | |||
|
See All Discussions